Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G

Kristen A Clarkson1, Robert W Frenck2, Michelle Dickey2

  • 1Department of Enteric Infections, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.

Msphere
|September 24, 2020
PubMed

Insights

Controlled human infection models (CHIMs) assessed immune responses to Shigella sonnei. Higher baseline IgA responses were linked to a reduced risk of shigellosis, suggesting potential correlates of immunity for vaccine development.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Vaccinology

Background:

  • Shigella causes severe diarrhea, particularly in children in low- and middle-income countries.
  • Controlled human infection models (CHIMs) are crucial for early vaccine efficacy assessment.
  • Defining correlates of immunity for shigellosis is essential for vaccine development.

Purpose of the Study:

  • To characterize immune responses following infection with Shigella sonnei 53G in a CHIM.
  • To identify potential correlates of protection against shigellosis.
  • To inform the design of effective Shigella vaccines.

Main Methods:

  • A lyophilized Shigella sonnei 53G strain was used in a CHIM to establish a safe and reproducible infection dose.
  • Immune responses, including inflammatory markers, antibody titers (serum and mucosal), and B cell populations, were measured pre- and post-challenge.
  • Association between clinical outcomes and immune responses was analyzed.

Main Results:

  • Shigella sonnei 53G infection induced robust intestinal inflammation and antigen-specific antibodies.
  • Elevated baseline lipopolysaccharide (LPS)-specific serum IgA and IgA-secreting memory B cell responses were associated with a reduced risk of disease.
  • No association was found between clinical disease and systemic or functional antibody responses post-challenge.

Conclusions:

  • Immune responses in a Shigella sonnei CHIM provide insights into potential protective mechanisms.
  • Baseline IgA responses may play a role in modulating disease severity and warrant further investigation as correlates of immunity.
  • Findings can guide the development of Shigella vaccines inducing protective immune responses.

Related Concept Videos